Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer
Abstract We construct risk predictors using polygenic scores (PGS) computed from common Single Nucleotide Polymorphisms (SNPs) for a number of complex disease conditions, using L1-penalized regression (also known as LASSO) on case-control data from UK Biobank. Among the disease conditions studied ar...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0bbe05be1ad42e9b5b0912d11a4bc34 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d0bbe05be1ad42e9b5b0912d11a4bc34 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d0bbe05be1ad42e9b5b0912d11a4bc342021-12-02T15:09:33ZGenomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer10.1038/s41598-019-51258-x2045-2322https://doaj.org/article/d0bbe05be1ad42e9b5b0912d11a4bc342019-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-51258-xhttps://doaj.org/toc/2045-2322Abstract We construct risk predictors using polygenic scores (PGS) computed from common Single Nucleotide Polymorphisms (SNPs) for a number of complex disease conditions, using L1-penalized regression (also known as LASSO) on case-control data from UK Biobank. Among the disease conditions studied are Hypothyroidism, (Resistant) Hypertension, Type 1 and 2 Diabetes, Breast Cancer, Prostate Cancer, Testicular Cancer, Gallstones, Glaucoma, Gout, Atrial Fibrillation, High Cholesterol, Asthma, Basal Cell Carcinoma, Malignant Melanoma, and Heart Attack. We obtain values for the area under the receiver operating characteristic curves (AUC) in the range ~0.58–0.71 using SNP data alone. Substantially higher predictor AUCs are obtained when incorporating additional variables such as age and sex. Some SNP predictors alone are sufficient to identify outliers (e.g., in the 99th percentile of polygenic score, or PGS) with 3–8 times higher risk than typical individuals. We validate predictors out-of-sample using the eMERGE dataset, and also with different ancestry subgroups within the UK Biobank population. Our results indicate that substantial improvements in predictive power are attainable using training sets with larger case populations. We anticipate rapid improvement in genomic prediction as more case-control data become available for analysis.Louis LelloTimothy G. RabenSoke Yuen YongLaurent C. A. M. TellierStephen D. H. HsuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-16 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Louis Lello Timothy G. Raben Soke Yuen Yong Laurent C. A. M. Tellier Stephen D. H. Hsu Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer |
description |
Abstract We construct risk predictors using polygenic scores (PGS) computed from common Single Nucleotide Polymorphisms (SNPs) for a number of complex disease conditions, using L1-penalized regression (also known as LASSO) on case-control data from UK Biobank. Among the disease conditions studied are Hypothyroidism, (Resistant) Hypertension, Type 1 and 2 Diabetes, Breast Cancer, Prostate Cancer, Testicular Cancer, Gallstones, Glaucoma, Gout, Atrial Fibrillation, High Cholesterol, Asthma, Basal Cell Carcinoma, Malignant Melanoma, and Heart Attack. We obtain values for the area under the receiver operating characteristic curves (AUC) in the range ~0.58–0.71 using SNP data alone. Substantially higher predictor AUCs are obtained when incorporating additional variables such as age and sex. Some SNP predictors alone are sufficient to identify outliers (e.g., in the 99th percentile of polygenic score, or PGS) with 3–8 times higher risk than typical individuals. We validate predictors out-of-sample using the eMERGE dataset, and also with different ancestry subgroups within the UK Biobank population. Our results indicate that substantial improvements in predictive power are attainable using training sets with larger case populations. We anticipate rapid improvement in genomic prediction as more case-control data become available for analysis. |
format |
article |
author |
Louis Lello Timothy G. Raben Soke Yuen Yong Laurent C. A. M. Tellier Stephen D. H. Hsu |
author_facet |
Louis Lello Timothy G. Raben Soke Yuen Yong Laurent C. A. M. Tellier Stephen D. H. Hsu |
author_sort |
Louis Lello |
title |
Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer |
title_short |
Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer |
title_full |
Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer |
title_fullStr |
Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer |
title_full_unstemmed |
Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer |
title_sort |
genomic prediction of 16 complex disease risks including heart attack, diabetes, breast and prostate cancer |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/d0bbe05be1ad42e9b5b0912d11a4bc34 |
work_keys_str_mv |
AT louislello genomicpredictionof16complexdiseaserisksincludingheartattackdiabetesbreastandprostatecancer AT timothygraben genomicpredictionof16complexdiseaserisksincludingheartattackdiabetesbreastandprostatecancer AT sokeyuenyong genomicpredictionof16complexdiseaserisksincludingheartattackdiabetesbreastandprostatecancer AT laurentcamtellier genomicpredictionof16complexdiseaserisksincludingheartattackdiabetesbreastandprostatecancer AT stephendhhsu genomicpredictionof16complexdiseaserisksincludingheartattackdiabetesbreastandprostatecancer |
_version_ |
1718387840688062464 |